BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 32355277)

  • 1. Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.
    Zhong XF; Sun X
    Acta Pharmacol Sin; 2020 Jul; 41(7):928-935. PubMed ID: 32355277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery.
    Della Rocca J; Liu D; Lin W
    Acc Chem Res; 2011 Oct; 44(10):957-68. PubMed ID: 21648429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity-boosted cancer immunotherapy based on nanoscale metal-organic frameworks.
    Li Q; Liu Y; Zhang Y; Jiang W
    J Control Release; 2022 Jul; 347():183-198. PubMed ID: 35526612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic Therapy Based on Nanoscale Metal-Organic Frameworks: From Material Design to Cancer Nanotherapeutics.
    Guan Q; Li YA; Li WY; Dong YB
    Chem Asian J; 2018 Nov; 13(21):3122-3149. PubMed ID: 30183134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
    Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
    Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale Metal-Organic Frameworks for Therapeutic, Imaging, and Sensing Applications.
    Lu K; Aung T; Guo N; Weichselbaum R; Lin W
    Adv Mater; 2018 Sep; 30(37):e1707634. PubMed ID: 29971835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
    Lu K; He C; Guo N; Chan C; Ni K; Lan G; Tang H; Pelizzari C; Fu YX; Spiotto MT; Weichselbaum RR; Lin W
    Nat Biomed Eng; 2018 Aug; 2(8):600-610. PubMed ID: 31015630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Targeting and Positron Emission Tomography Imaging of Tumor with Intrinsically Radioactive Metal-Organic Frameworks Nanomaterials.
    Chen D; Yang D; Dougherty CA; Lu W; Wu H; He X; Cai T; Van Dort ME; Ross BD; Hong H
    ACS Nano; 2017 Apr; 11(4):4315-4327. PubMed ID: 28345871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic Acid Functionalized Zirconium-Based Metal-Organic Frameworks as Drug Carriers for Active Tumor-Targeted Drug Delivery.
    Dong H; Yang GX; Zhang X; Meng XB; Sheng JL; Sun XJ; Feng YJ; Zhang FM
    Chemistry; 2018 Nov; 24(64):17148-17154. PubMed ID: 30125400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy.
    Zeng L; Cao Y; He L; Ding S; Bian XW; Tian G
    J Mater Chem B; 2021 Jan; 9(2):208-227. PubMed ID: 33215626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective of nanoscale metal organic frameworks [NMOFs] for cancer therapy.
    Shait Mohammed MR; Ahmad V; Ahmad A; Tabrez S; Choudhry H; Zamzami MA; Bakhrebah MA; Ahmad A; Wasi S; Mukhtar H; Khan MI
    Semin Cancer Biol; 2021 Feb; 69():129-139. PubMed ID: 31866477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscale covalent organic frameworks: from controlled synthesis to cancer therapy.
    He X; Jiang Z; Akakuru OU; Li J; Wu A
    Chem Commun (Camb); 2021 Nov; 57(93):12417-12435. PubMed ID: 34734601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in nanoscale metal-organic frameworks for drug release and cancer therapy.
    He L; Liu Y; Lau J; Fan W; Li Q; Zhang C; Huang P; Chen X
    Nanomedicine (Lond); 2019 May; 14(10):1343-1365. PubMed ID: 31084393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoscale metal-organic frameworks for combined photodynamic & radiation therapy in cancer treatment.
    Liu J; Yang Y; Zhu W; Yi X; Dong Z; Xu X; Chen M; Yang K; Lu G; Jiang L; Liu Z
    Biomaterials; 2016 Aug; 97():1-9. PubMed ID: 27155362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies and applications of covalent organic frameworks as promising nanoplatforms in cancer therapy.
    Valenzuela C; Chen C; Sun M; Ye Z; Zhang J
    J Mater Chem B; 2021 Apr; 9(16):3450-3483. PubMed ID: 33909746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
    Wei Q; Wu Y; Liu F; Cao J; Liu J
    J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of nanoscale metal-organic frameworks as imaging agents in biology and medicine.
    Demir Duman F; Forgan RS
    J Mater Chem B; 2021 Apr; 9(16):3423-3449. PubMed ID: 33909734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in nanoscale metal-organic frameworks for cancer chemodynamic therapy.
    Ji M; Liu H; Gou J; Yin T; He H; Zhang Y; Tang X
    Nanoscale; 2023 May; 15(20):8948-8971. PubMed ID: 37129051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-Organic Framework-Based Nanomedicine Platforms for Drug Delivery and Molecular Imaging.
    Cai W; Chu CC; Liu G; Wáng YX
    Small; 2015 Oct; 11(37):4806-22. PubMed ID: 26193176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.